Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Akela Pharma Inc. AKLPF

"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."

GREY:AKLPF - Post Discussion

Akela Pharma Inc. > Resignation of Raj M
View:
Post by waIlabe_short on Oct 20, 2009 7:56am

Resignation of Raj M

Akela Pharma announces director resignation

AUSTIN, TX, Oct. 20 /CNW Telbec/- Akela Pharma, Inc., (TSX: AKL) a leader in the development oftherapeutics for the treatment of pain, and the company's wholly ownedsubsidiary, PharmaForm, today announced the resignation of RajMaheshwari from his position as a non-executive director of thecompany.Mr. Maheshwariserved on Akela Pharma's board since June 2008.There are no current plans to replace this position, and the currentfive members will continue to carry out the duties of the board.

"Raj has been a valuable member of Akela's board and we thank himfor his many contributions to the company during the time of hisservice," stated Gregory McKee, president and chief executive officerof Akela Pharma. "We wish Raj well in all his future endeavors."

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities